Victoria Socha

DocwireNews

Children with advanced chronic kidney disease (CKD) commonly experience anemia of CKD, resulting in significant impact on quality of life, developmental milestones, and physical activity. Managing pediatric anemia of CKD with erythropoietins that require regular injection is challenging. Daprodustat, a hypoxia-inducible factor prolyl hydroxylase enzyme inhibitor, has demonstrated noninferiority for both efficacy and safety in adults with anemia of CKD, in both dialysis and nondialysis populations, and is administered by mouth.During a poster session at the NKF 2023 Spring Clinical Meetings, Thomas F. Hiemstra, MD, PhD, and colleagues described protocol for a global trial of daprodustat for treatment for anemia in patients 3 months to 17 years with CKD stage &ge;3. The poster was titled Protocol for Erythropoiesis via a Novel PHI Daprodustat&ndash;Pediatric (ASCEND-P) Trial.The global, prospective, single-arm, interventional basket trial will consist of two subtrials of 60 patients receiving dialysis and 60 patients not receiving dialysis. Each subtrial will include an integrated 4-week pharmacokinetic (PK) phase in up to 24 participants, allowing in-trial adaptation of the dosing strategy if actual PK deviates from model assumptions.Participants will be treated with oral daprodustat to achieve a target hemoglobin concentration of 10-12 g/dL. Participants will be followed every 4 weeks for 28 weeks and then every 4 to 8 weeks for 56 weeks. Recruitment will be from the CoCOA-CKD prospective cohort study of anemia in children with CKD.The primary outcome of interest is the safety of daprodustat in a pediatric population, determined by the incidence of adverse events, serious adverse events, and adverse events of special interest. Hemoglobin response and PK are secondary outcomes.In summary, the researchers said, &ldquo;The ASCEND-P single-arm basket trial of daprodustat for anemia of CKD will evaluate the safety and efficacy of daprodustat in both dialysis and predialysis pediatric patients. The design of the ASCEND-P study as a basket trial within a basket cohort study, with an adaptive approach to PK, provides an efficient and patient-centered way to evaluate the use of daprodustat as an oral agent for the treatment of anemia in CKD in pediatric populations.&rdquo;The study is funded by GSK(Study 214066).Source: Hiemstra TF, Vick JG, Roberts JC. Protocol for the erythropoiesis via a novel PHI daprodustat&shy;&ndash;pediatric (ASCEND-P) trial. Poster #181. Abstract of a poster presented at the National Kidney Foundation Spring Clinical Meetings 2023; April 11-15, 2023; Austin, Texas.

Jordana Jampel

FDA Approves Novel Blood Test for Alzheimer’s Detection

Dementia

Andrew Moreno

Is Plasma Mannose-Binding Lectin a Clue to Higher VTE Risk?

Katie Kosko

EMBER-3: Imlunestrant Plus Abemaciclib Improves PFS in ER+ Breast Cancer

HR Breast Cancer

Latest News

Protocol for Trial of Daprodustat for Anemia in Pediatric Patients With CKD

Anemia and Kidney Disease

Study protocol for a trial examining use of daprodustat in pediatric anemia related to CKD.

Daprodustat for pediatric anemia of CKD

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe